Tag: bioequivalence

FDA Authorization of Generics: Legal Basis and Approval Process

The FDA approves generic drugs through the Hatch-Waxman Act's ANDA pathway, requiring identical active ingredients, bioequivalence, and strict manufacturing standards. Generics cost 80-85% less and make up 90% of U.S. prescriptions.

Special Populations in Bioequivalence: Age and Sex Considerations

Bioequivalence studies must reflect real patients. Learn how age and sex differences impact generic drug safety and why regulators now require balanced enrollment in clinical trials.

About

Healthcare Information